Note: Ingredients listed on restricted chemical lists
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
60-100
General Information
Revision date
2024-09-30
Product name
Dicyclomine Hydrochloride Injection, USP
Product Synonyms
dicyclomine hydrochloride injection
1.2.1 Relevant identified uses
antispasmodic and anticholinergic (antimuscarinic) agent indicated for the treatment of functional bowel/irritable bowel syndrome
Manufacturer Name
Somerset Therapeutics
Icons in SDS
Company Information
company name
Somerset Therapeutics
Section 2
SECTION 2: Hazards identification
2.2 Label elements
Emergency Overview The product contains no substances which at their given concentration, are considered to be hazardous to health Appearance Contained in a Ampoule Physical state Liquid Odor No information available Chemical Name dicyclomine hydrochloride Symptoms Dry Mouth, Dizziness, blurry vision, nausea, somnolence, asthenia, nervousness. The most serious adverse reactions reported with dicyclomine hydrochloride include cardiovascular and central nervous system symptoms. Chemical Name dicyclomine hydrochloride
Medical Conditions Generally Aggravated by Exposure
Dicyclomine hydrochloride needs to be used with caution inconditions characterized by tachyarrhythmia such as thyrotoxicosis,congestive heart failure and in cardiac surgery, where they mayfurther accelerate the heart rate.
Further information
Over the counter drugs in their solid form are considered exempt under the criteria of the Federal
